Weigao Group Schedules 25 August Board Meeting to Review 1H 2026 Interim Results and Dividend Proposal

Bulletin Express07-27

Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) has issued a notice convening its board of directors for 25 August 2026. The meeting agenda includes:

• Approval and publication of the unaudited consolidated results for the six months ended 30 June 2026. • Consideration of an interim dividend declaration and payment, if any.

The announcement, dated 27 July 2026, lists the current board composition as four executive directors (Long Jing, Cong Rinan, Lu Junqiang and Wang Daoming), two non-executive directors (Chen Lin and Tang Zhengpeng) and four independent non-executive directors (Li Guohui, Meng Hong, Li Qiang and Sun Heng).

Results and dividend details will be disclosed following the board’s deliberations on the specified date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment